SynthesisFrontiers in oncology2022

Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk.

Chenglu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.